SHF Holdings And 3 Other Stocks Under $2 Insiders Are Buying
SHF Holdings And 3 Other Stocks Under $2 Insiders Are Buying
SHF Holdings和其他3只2美元以下的股票业内人士正在买入
The Dow Jones closed higher by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周四收盘上涨60多点。当内部人士买入或卖出股票时，这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将其视为其整体投资或交易决策中的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的细价股内幕交易。欲了解更多，请查看 本辛加的内幕交易 平台。
SHF Holdings
SHF Holdings
- The Trade: SHF Holdings, Inc. (NASDAQ:SHFS) Chief Legal Officer Donald Emmi acquired a total of 66,000 shares an average price of $0.87. To acquire these shares, it cost around $57,420. The company's CEO also bought 20,000 shares of the company.
- What's Happening: On Nov. 14, SHF Hldgs posted a loss for the third quarter.
- What SHF Holdings Does: SHF Holdings Inc is a financial services provider to cannabis-related businesses.
- 交易：SHF Holdings, Inc.（纳斯达克股票代码：SHFS）首席法务官唐纳德·艾米 共收购了 66,000 股股票 平均价格为0.87美元。收购这些股票的成本约为57,420美元。该公司的首席执行官还购买了该公司的20,000股股票。
- 发生了什么：11月14日，SHF Hldgs公布了第三季度的亏损。
- SHF Holdings做什么：SHF Holdings Inc是大麻相关企业的金融服务提供商。
Quince Therapeutics
昆斯疗法
- The Trade: Quince Therapeutics, Inc. (NASDAQ:QNCX) Director David Lamond acquired a total of 57,369 shares at an average price of $1.01. To acquire these shares, it cost around $58,134.
- What's Happening: On Oct. 23, Quince Therapeutics announced the successful completion of its acquisition of EryDel S.p.A.
- What Quince Therapeutics Does: Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases.
- 交易：Quince Therapeutics, Inc.（纳斯达克股票代码：QNCX）董事大卫·拉蒙德 共收购了57,369股股票 平均价格为1.01美元。收购这些股票的成本约为58,134美元。
- 发生了什么：10月23日，Quince Therapeutics宣布成功完成对Erydel S.p.A的收购。
- Quince Therapeutics的所作所为：Quince Therapeutics Inc是一家临床前阶段的生物制药公司，专注于开发针对使人衰弱和罕见疾病的创新精准疗法。
Check This Out: 'I Like It Very Much': Jim Cramer Bullish On This Financial Stock Up 75% YTD
看看这个： “我非常喜欢”：吉姆·克莱默看好这只金融股年初至今上涨75％
Silo Pharma
Silo Pharma
- The Trade: Silo Pharma, Inc. (NASDAQ:SILO) President and CEO Eric Weisblum acquired a total of 1,000 shares at an average price of $1.38. The insider spent around $1,376 to buy those shares.
- What's Happening: On Nov. 21, Silo Pharma entered into exclusive license agreement with Medspray Pharma BV for intranasal technology used in SPC-15 treatment for PTSD.
- What Silo Pharma Does: SILO Pharma Inc is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.
- 交易：Silo Pharma, Inc.（纳斯达克股票代码：SILO）总裁兼首席执行官埃里克·韦斯布鲁姆 共收购了 1,000 股股份 平均价格为1.38美元。内幕人士花费了大约1376美元购买了这些股票。
- 发生了什么：11月21日，Silo Pharma与Medspray Pharma BV就用于创伤后应激障碍 SPC-15 治疗的鼻内技术签订了独家许可协议。
- Silo Pharma的所作所为：SILO Pharma Inc是一家处于发展阶段的生物制药公司，专注于将传统疗法与迷幻药研究相结合。
Upexi
Upexi
- The Trade: Upexi, Inc. (NASDAQ:UPXI) CEO Allan Marshall acquired a total of 90,001 shares at an average price of $0.94. The insider spent around $84,952 to buy those shares.
- What's Happening: On Nov. 20, Upexi posted a wider-than-expected quarterly loss.
- What Upexi Does: Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.
- 交易：Upexi, Inc.（纳斯达克股票代码：UPXI）首席执行官艾伦·马歇尔 共收购了 90,001 股股票 平均价格为0.94美元。内幕人士花费了约84,952美元购买了这些股票。
- 发生了什么：11月20日，Upexi公布的季度亏损超出预期。
- Upexi的作用：Upexi Inc是聚合领域的创新者，通过结合消费者数据和垂直整合来扩大多个行业的品牌规模，从而加速亚马逊和电子商务业务的发展，同时通过不断增长的分销网络降低成本。
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道